Effectiveness of intrapartum antibiotic prophylaxis for prevention of early-onset group B streptococcal disease

Obstetrics and Gynecology

Volumn 121, Issue 3, 2013, Pages 570-577

  Fairlie, Tarayn ^a   Zell, Elizabeth R ^a   Schrag, Stephanie ^a  

^a NATIONAL CENTER FOR IMMUNIZATION AND RESPIRATORY DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMPICILLIN; CEFAZOLIN; CLINDAMYCIN; PENICILLIN DERIVATIVE;

ADULT; ANTIBIOTIC PROPHYLAXIS; ARTICLE; BACTERIAL TRANSMISSION; COHORT ANALYSIS; DRUG EFFICACY; FEMALE; GROUP B STREPTOCOCCAL INFECTION; HUMAN; INTRAPARTUM CARE; MAJOR CLINICAL STUDY; MATERNAL CARE; NEWBORN; OUTCOME ASSESSMENT; PREMATURE LABOR; PRIORITY JOURNAL; SECONDARY ANALYSIS; TREATMENT DURATION;

ADULT; AMPICILLIN; ANTI-BACTERIAL AGENTS; ANTIBIOTIC PROPHYLAXIS; CLINDAMYCIN; FEMALE; HUMANS; PREGNANCY; PREMATURE BIRTH; STREPTOCOCCAL INFECTIONS; STREPTOCOCCUS AGALACTIAE; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84876231074     PISSN: 00297844     EISSN: 1873233X     Source Type: Journal    
DOI: 10.1097/AOG.0b013e318280d4f6     Document Type: Article

References (24)

1. Centers for Disease Control and Prevention. Prevention of perinatal group B streptococcal disease - revised guidelines from CDC, 2010. MMWR Recomm Rep 2010;59:1-36.
2. Committee on Infectious Diseases; Committee on Fetus and Newborn. Baker CJ, Byinton CL, Polin RA. Policy statement - Recommendations for prevention of perinatal group B streptococcal disease. Committee on Infectious Diseases and Committee on the Fetus and Newborn. Pediatrics 2011;128:611-6.
3. Prevention of group B streptococcal disease in newborns. Committee Opinion No. 485. American College of Obstetricians and Gynecologists. Obstet Gynecol 2011;117:1019-27.
4. Stoll BJ, Hansen NI, Sanchez PJ, Faix RG, Poindexter BB, Van Meurs KP, et al. Early onset neonatal sepsis: the burden of group B streptococcal and Escherichia coli disease continues. Pediatrics 2011;127:817-26.
5. Van Dyke MK, Phares CR, Lynfield R, Thomas AR, Arnold KE, Craig AS, et al. Evaluation of universal antenatal screening for group B streptococcus. N Engl J Med 2009;360:2626-36.
6. Matteson KA, Lievense SP, Catanzaro B, Phipps MG. Intra-partum group B streptococcal prophylaxis in patients reporting a penicillin allergy. Obstet Gynecol 2008;111:356-64.
7. Boyer KM, Gotoff SP. Prevention of early-onset neonatal group B streptococcal disease with selective intrapartum chemopro-phylaxis. N Engl J Med 1986;314:1665-9.
8. Centers for Disease Control and Prevention (CDC). Perinatal group B streptococcal disease after universal screening recommendations - United States, 2003-2005. MMWR Morb Mortal Wkly Rep 2007;56:701-5.
9. Pattanayak CW, Rubin DB, Zell ER. Propensity score methods for creating covariate balance in observational studies [in Spanish]. Rev Esp Cardiol 2011;64:897-903.
10. Ahmed A, Young JB, Love TE, Levesque R, Pitt B. A propensity-matched study of the effects of chronic diuretic therapy on mortality and hospitalization in older adults with heart failure Int J Cardiol 2008;125:246-53.
11. Lin FY, Weisman LE, Azimi P, Young AE, Chang K, Cielo M, et al. Assessment of intrapartum antibiotic prophylaxis for the prevention of early-onset group B streptococcal disease. Pediatr Infect Dis J 2011;30:759-63.
12. Philipson A, Sabath LD, Charles D. Erythromycin and clinda-mycin absorption and elimination in pregnant women. Clin Pharmacol Ther 1976;19:68-77.
13. Philipson A, Sabath LD, Charles D. Transplacental passage of erythromycin and clindamycin. N Engl J Med 1973;288: 1219-21.
14. Muller AE, Mouton JW, Oostvogel PM, Dorr PJ, Voskuyl RA, DeJongh J, et al. Pharmacokinetics of clindamycin in pregnant women in the peripartum period. Antimicrob Agents Chemother 2010;54:2175-81.
15. Castor ML, Whitney CG, Como-Sabetti K, Facklam RR, Ferrieri P, Bartkus JM, et al. Antibiotic resistance patterns in invasive group B streptococcal isolates. Infect Dis Obstet Gynecol 2008;2008:727505.
16. Kelkar PS, Li JT. Cephalosporin allergy. N Engl J Med 2001; 345:804-9.
17. Chaudhuri K, Gonzales J, Jesurun CA, Ambat MT, Mandal-Chaudhuri S. Anaphylactic shock in pregnancy: a case study and review of the literature. Int J Obstet Anesth 2008;17:350-7.
18. Dunn AB, Blomquist J, Khouzami V. Anaphylaxis in labor secondary to prophylaxis against group B streptococcus. A case report. J Reprod Med 1999;44:381-4.
19. Sheikh J. Intrapartum anaphylaxis to penicillin in a woman with rheumatoid arthritis who had no prior penicillin allergy. Ann Allergy Asthma Immunol 2007;99:287-9.
20. Gei AF, Pacheco LD, Vanhook JW, Hankins GD. The use of a continuous infusion of epinephrine for anaphylactic shock during labor. Obstet Gynecol 2003;102:1332-5.
21. Illuzzi JL, Bracken MB. Duration of intrapartum prophylaxis for neonatal group B streptococcal disease: a systematic review. Obstet Gynecol 2006;108:1254-65.
22. DiPersio LP, DiPersio JR. High rates of erythromycin and clindamycin resistance among OBGYN isolates of group B streptococcus. Diagn Microbiol Infect Dis 2006;54:79-82.
23. Phares C, Lynfield R, Farley M, Mohle-Boetani J, Harrison L, Petit S, et al. Epidemiology of invasive group B streptococcal disease in the United States, 1999-2005. JAMA 2008;299:2056-65.
24. Schrag SJ, Verani JR. Intrapartum antibiotic prophylaxis for the prevention of perinatal group B streptococcal disease: Experience in the United States and implications for a potential group B streptococcal vaccine. Vaccine. 2012 Dec 3 [Epub ahead of print].